Semaglutide, a medication originally developed for managing type 2 diabetes, has quickly gained widespread recognition for its remarkable benefits beyond diabetes control, including significant weight loss and improvements in heart health. This breakthrough treatment belongs to the GLP-1 receptor agonist class, which works by mimicking the hormone glucagon-like peptide-1 (GLP-1) https://nse-india37057.losblogos.com/30361818/semaglutide-a-breakthrough-in-diabetes-weight-loss-and-cardiovascular-care